ArticleTrials2020

The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.

Tao Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.